- UroToday Home
- Recent Abstracts
- Urologic Oncology
Prostate Cancer
Myriad’s Prolaris® test shown to significantly predict biochemical recurrence risk after prostatectomy
February 3, 2012
GU Cancers Symposium 2012 - Role of dose escalation and supplemental androgen deprivation - Session Highlights
February 3, 2012
GU Cancers Symposium 2012 - Hypofractionation for prostate cancer: Is less better? - Session Highlights
February 3, 2012
Intra-fraction motion during extreme hypofractionated radiotherapy of the prostate using pre- and post-treatment imaging - Abstract
February 2, 2012
The COMPASs Study: Community Preferences for Prostate cAncer Screening. Protocol for a quantitative preference study - Abstract
February 2, 2012
Frequency and determinants of disagreement and error in Gleason scores: A population-based study of prostate cancer - Abstract
February 2, 2012
Dynamic contrast-enhanced MR imaging findings of bone metastasis in patients with prostate cancer - Abstract
February 2, 2012
Factors implicated in radiation therapy failure and radiosensitization of prostate cancer - Abstract
February 2, 2012
Human prostate cancer ZIP1/zinc/citrate genetic/metabolic relationship in the TRAMP prostate cancer animal model - Abstract
February 2, 2012
Prognostic determinants in prostate cancer - Abstract
February 2, 2012
Effect of dietary polyunsaturated fatty acids on castration-resistant Pten-null prostate cancer - Abstract
February 2, 2012
α-Mangostin, a xanthone from mangosteen fruit, promotes cell cycle arrest in prostate cancer and decreases xenograft tumor growth - Abstract
February 2, 2012
Recurrent deletion of CHD1 in prostate cancer with relevance to cell invasiveness - Abstract
February 2, 2012